A research paper co-authored by A. Mark Fendrick, MD, Director of the Center for Value-Based Insurance Design, assesses the impacts of new medical innovations for COVID-19, including both vaccines and therapeutics. These innovations saved at least 699,110 life years in the U.S. and $371.6 billion. In addition, the availability of vaccines and therapeutics resulted in a value of $933.1 billion.